ACUTE MONOCYTIC LEUKEMIA
Clinical trials for ACUTE MONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for patients with no other options
Disease control Recruiting nowThis is a first-in-human study testing a new drug called STX-0712 in patients with advanced forms of blood cancer (CMML and AML) who have no remaining standard treatment options. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the canc…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for frail leukemia patients: 3-Drug combo targets Treatment-Resistant cancer
Disease control Recruiting nowThis study is testing whether adding a drug called chidamide to an existing two-drug combination (venetoclax and azacytidine) works better for newly diagnosed acute monocytic leukemia patients who are too old or frail for intensive chemotherapy. The trial aims to see if this thre…
Matched conditions: ACUTE MONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC